RUBIS Shares: Voting Rights and Financial Insights Overview

RUBIS Shares and Voting Rights Overview
RUBIS recently provided vital information about its total voting rights and shares. This data is crucial for shareholders and potential investors looking to understand the company’s governance and equity structure. The report highlights the situation as of the end of July 2025, ensuring that shareholders are well-informed about their voting power and the number of shares in circulation.
Details on Voting Rights and Shares
As specified in the regulations governing the French commercial sector, the number of ordinary shares was reported as 103,361,773. In addition to the total shares, an important point to note is that all these shares correspond directly to the same number of theoretical voting rights, affirming the transparency in company governance.
Ordinary Shares Breakdown
The shares in question are ordinary shares, possessing a par value of €1.25 each. The number of exercisable voting rights was recorded at 103,103,077, demonstrating the direct impact of company policies on shareholder voting capabilities. This figure excludes shares bought back by the company, which are not eligible for voting rights in compliance with French laws.
Contact Information for Shareholders
For shareholders seeking more information about their investments or the company’s governance, RUBIS has made their legal department accessible. They can be contacted directly by phone: +33 (0)1 44 17 95 95. This gesture reflects RUBIS's commitment to transparency and shareholder engagement.
Importance of Staying Informed
Staying updated with such details about voting rights and share distributions is critical for all stakeholders involved with RUBIS. Knowing these figures enables investors to make informed decisions regarding their stakes in the company. In a rapidly changing financial landscape, this knowledge is more important than ever.
Conclusion on RUBIS' Shareholder Engagement
Overall, RUBIS continues to uphold a culture of transparency by sharing essential information about voting rights and shareholder structure. Understanding the implications of these figures not only helps to foster trust between the company and its investors but also enhances the overall integrity of the market.
Frequently Asked Questions
What is the total number of ordinary shares for RUBIS?
As of July 31, 2025, the total number of ordinary shares is 103,361,773.
How many exercisable voting rights does a RUBIS shareholder have?
Shareholders currently have 103,103,077 exercisable voting rights.
Where can I find more information about RUBIS shares?
For further information, you can contact the RUBIS legal department at +33 (0)1 44 17 95 95.
Are there any shares bought back by RUBIS impacting voting rights?
Yes, shares bought back by RUBIS are excluded from the totals affecting voting rights.
What is the par value of RUBIS's ordinary shares?
The par value of each ordinary share is €1.25.
About The Author
Contact Addison Perry privately here. Or send an email with ATTN: Addison Perry as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.